{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33655"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33655","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Characterizing the Postprandial Glucose Metabolic Response in Naturally Cycling Females and Hormonal Contraceptive Users","abstract":"Hormonal contraceptive use has been associated with alterations in glucose metabolism, increasing the risk of insulin resistance and metabolic disease, such as type 2 diabetes. However, whether certain progestins (i.e. second-generation levonorgestrel) within prevalent hormonal contraceptive methods affect postprandial glucose handling remains unclear. Therefore, we investigated glucose regulation, body composition, and circulating hormone concentrations in young healthy females who were either naturally cycling (NAT) or using either a second-generation levonorgestrel-containing oral contraceptive pill (OCP) or a levonorgestrel-releasing intrauterine device (IUD). Eighteen young healthy females (NAT: n = 8; OCP: n = 5; IUD: n = 5; aged 23 ± 5 years) participated in this cross-sectional study. Participants completed a screening visit followed by an experimental visit involving dual-energy X-ray absorptiometry (DXA) and a 2-hour 75g oral glucose tolerance test (OGTT). Glucose and insulin concentrations were measured throughout the OGTT, and indices of insulin sensitivity were calculated. We found a significant effect of time for both glucose and insulin concentrations during the OGTT (p < 0.0001), reflecting the expected postprandial response. Fasting glucose was higher in the IUD group than the OCP group (p = 0.015); however, no between-group differences were observed in other markers of glucose regulation, insulin sensitivity indices, body composition, or circulating concentrations of 17β-estradiol, progesterone, or levonorgestrel (p > 0.05). These findings suggest that second-generation levonorgestrel-containing OCPs and levonorgestrel-releasing IUDs may not substantially alter postprandial glucose handling or insulin sensitivity compared with NAT females. However, these findings should be interpreted cautiously given the modest samples size, and larger studies are needed to confirm whether hormonal contraceptive use influences metabolic health in young healthy females.","abstract_html":"Hormonal contraceptive use has been associated with alterations in glucose metabolism, increasing the risk of insulin resistance and metabolic disease, such as type 2 diabetes. However, whether certain progestins (i.e. second-generation levonorgestrel) within prevalent hormonal contraceptive methods affect postprandial glucose handling remains unclear. Therefore, we investigated glucose regulation, body composition, and circulating hormone concentrations in young healthy females who were either naturally cycling (NAT) or using either a second-generation levonorgestrel-containing oral contraceptive pill (OCP) or a levonorgestrel-releasing intrauterine device (IUD). Eighteen young healthy females (NAT: n = 8; OCP: n = 5; IUD: n = 5; aged 23 ± 5 years) participated in this cross-sectional study. Participants completed a screening visit followed by an experimental visit involving dual-energy X-ray absorptiometry (DXA) and a 2-hour 75g oral glucose tolerance test (OGTT). Glucose and insulin concentrations were measured throughout the OGTT, and indices of insulin sensitivity were calculated. We found a significant effect of time for both glucose and insulin concentrations during the OGTT (p &lt; 0.0001), reflecting the expected postprandial response. Fasting glucose was higher in the IUD group than the OCP group (p = 0.015); however, no between-group differences were observed in other markers of glucose regulation, insulin sensitivity indices, body composition, or circulating concentrations of 17β-estradiol, progesterone, or levonorgestrel (p &gt; 0.05). These findings suggest that second-generation levonorgestrel-containing OCPs and levonorgestrel-releasing IUDs may not substantially alter postprandial glucose handling or insulin sensitivity compared with NAT females. However, these findings should be interpreted cautiously given the modest samples size, and larger studies are needed to confirm whether hormonal contraceptive use influences metabolic health in young healthy females.","abstract_has_math":false,"creators":["Beriault, Gabrielle"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Kinesiology","school":null,"contributors":[],"advisors":["Bell, Kirsten"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:31:03Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25425"],"render_values":[{"text":"https://doi.org/10.71548/25425","href":"https://doi.org/10.71548/25425","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33655","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33655","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33655","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Bell, Kirsten"]},{"key":"dc:contributor.department","label":"Department","values":["Kinesiology"]},{"key":"dc:creator","label":"Author","values":["Beriault, Gabrielle"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-05T14:40:07Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Dissertation","Thesis"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33655","https://doi.org/10.71548/25425"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Hormonal contraceptive use has been associated with alterations in glucose metabolism, increasing the risk of insulin resistance and metabolic disease, such as type 2 diabetes. However, whether certain progestins (i.e. second-generation levonorgestrel) within prevalent hormonal contraceptive methods affect postprandial glucose handling remains unclear. Therefore, we investigated glucose regulation, body composition, and circulating hormone concentrations in young healthy females who were either naturally cycling (NAT) or using either a second-generation levonorgestrel-containing oral contraceptive pill (OCP) or a levonorgestrel-releasing intrauterine device (IUD). Eighteen young healthy females (NAT: n = 8; OCP: n = 5; IUD: n = 5; aged 23 ± 5 years) participated in this cross-sectional study. Participants completed a screening visit followed by an experimental visit involving dual-energy X-ray absorptiometry (DXA) and a 2-hour 75g oral glucose tolerance test (OGTT). Glucose and insulin concentrations were measured throughout the OGTT, and indices of insulin sensitivity were calculated. We found a significant effect of time for both glucose and insulin concentrations during the OGTT (p < 0.0001), reflecting the expected postprandial response. Fasting glucose was higher in the IUD group than the OCP group (p = 0.015); however, no between-group differences were observed in other markers of glucose regulation, insulin sensitivity indices, body composition, or circulating concentrations of 17β-estradiol, progesterone, or levonorgestrel (p > 0.05). These findings suggest that second-generation levonorgestrel-containing OCPs and levonorgestrel-releasing IUDs may not substantially alter postprandial glucose handling or insulin sensitivity compared with NAT females. However, these findings should be interpreted cautiously given the modest samples size, and larger studies are needed to confirm whether hormonal contraceptive use influences metabolic health in young healthy females."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Characterizing the Postprandial Glucose Metabolic Response in Naturally Cycling Females and Hormonal Contraceptive Users"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Bell, Kirsten"],"dc:contributor.department":["Kinesiology"],"dc:creator":["Beriault, Gabrielle"],"dc:date.accessioned":["2026-10-05T14:40:07Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Hormonal contraceptive use has been associated with alterations in glucose metabolism, increasing the risk of insulin resistance and metabolic disease, such as type 2 diabetes. However, whether certain progestins (i.e. second-generation levonorgestrel) within prevalent hormonal contraceptive methods affect postprandial glucose handling remains unclear. Therefore, we investigated glucose regulation, body composition, and circulating hormone concentrations in young healthy females who were either naturally cycling (NAT) or using either a second-generation levonorgestrel-containing oral contraceptive pill (OCP) or a levonorgestrel-releasing intrauterine device (IUD). Eighteen young healthy females (NAT: n = 8; OCP: n = 5; IUD: n = 5; aged 23 ± 5 years) participated in this cross-sectional study. Participants completed a screening visit followed by an experimental visit involving dual-energy X-ray absorptiometry (DXA) and a 2-hour 75g oral glucose tolerance test (OGTT). Glucose and insulin concentrations were measured throughout the OGTT, and indices of insulin sensitivity were calculated. We found a significant effect of time for both glucose and insulin concentrations during the OGTT (p < 0.0001), reflecting the expected postprandial response. Fasting glucose was higher in the IUD group than the OCP group (p = 0.015); however, no between-group differences were observed in other markers of glucose regulation, insulin sensitivity indices, body composition, or circulating concentrations of 17β-estradiol, progesterone, or levonorgestrel (p > 0.05). These findings suggest that second-generation levonorgestrel-containing OCPs and levonorgestrel-releasing IUDs may not substantially alter postprandial glucose handling or insulin sensitivity compared with NAT females. However, these findings should be interpreted cautiously given the modest samples size, and larger studies are needed to confirm whether hormonal contraceptive use influences metabolic health in young healthy females."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33655","https://doi.org/10.71548/25425"],"dc:title":["Characterizing the Postprandial Glucose Metabolic Response in Naturally Cycling Females and Hormonal Contraceptive Users"],"dc:type":["Dissertation","Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:31:03Z"}